World's Best Scientists 2026 revealed!
Sylvie Ménard

Sylvie Ménard

D-Index & Metrics

Medicine

D-Index
84
Citations
31147
World Ranking
14950
National Ranking
583

Overview

Sylvie Ménard is affiliated with the University of Milan in Italy and has conducted research across multiple disciplines, including Medicine and Engineering. Their work spans subfields such as Ocean Engineering, Cancer Research, Surgery, Pathology and Forensic Medicine, and Radiological and Ultrasound Technology.

The scientist's research topics cover a range of areas with a particular focus on breast cancer and oil and gas production techniques. The main topics addressed in their work include:

  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Oil and Gas Production Techniques
  • Occupational Health and Safety Research
  • Drilling and Well Engineering

Their recent publications feature two papers from 2024. One, published in the British Journal of Surgery, is titled "Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial." The other, appearing in the Offshore Technology Conference proceedings, is called "Enhancing Tubular Running Operations by Automation and Validating the Proof of Value in Well Construction Through an Intelligent and Autonomous Tong Solution."

These publications reflect an interdisciplinary approach that combines medical research on breast cancer treatment with applied engineering in offshore and well construction technologies.

Collaborative efforts are noted with several frequent co-authors, which include:

  • Roberto Agresti
  • Marco Sandri
  • Giuseppe Capri
  • Giulia Bianchi
  • Tiziana Triulzi

Their work has been disseminated primarily through venues such as the British Journal of Surgery and the Offshore Technology Conference, indicating a balance between clinical medical studies and technical engineering research.

Best Publications

  • MicroRNA gene expression deregulation in human breast cancer.

    Marilena V. Iorio;Manuela Ferracin;Chang Gong Liu;Angelo Veronese

  • MicroRNA Signatures in Human Ovarian Cancer

    Carlo M. Croce

  • Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2.

    Roberto Gennari;Sylvie Menard;Francesco Fagnoni;Luisa Ponchio

  • Biologic and therapeutic role of HER2 in cancer.

    Sylvie Ménard;Serenella Marja Pupa;Manuela Campiglio;Elda Tagliabue

  • Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

    Valentina Ciravolo;Veronica Huber;Gaia C. Ghedini;Elisabetta Venturelli

  • Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity

    S. Miotti;S. Canevari;S. Ménard;D. Mezzanzanica

  • High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.

    Mary L. Disis;Serenella M. Pupa;Julie R. Gralow;Ruggero Dittadi

  • Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

    A. Bergamaschi;E. Tagliabue;Therese Sorlie;Therese Sorlie;Bjorn Naume

  • New insights into the role of extracellular matrix during tumor onset and progression.

    Serenella M. Pupa;Sylvie Ménard;Stefania Forti;Elda Tagliabue

  • microRNA-205 Regulates HER3 in Human Breast Cancer

    Marilena V. Iorio;Patrizia Casalini;Claudia Piovan;Gianpiero Di Leva

  • Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

    Francesco Pezzella;Ugo Pastorino;Elda Tagliabue;Salvatore Andreola

  • Role of HER2 gene overexpression in breast carcinoma.

    Sylvie Ménard;Elda Tagliabue;Manuela Campiglio;Serenella M. Pupa

  • A Comparative Study of p53 Gene Mutations, Protein Accumulation, and Response to Cisplatin-based Chemotherapy in Advanced Ovarian Carcinoma

    S C Righetti;G Della Torre;S Pilotti;S Ménard

  • Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

    Ugo Pastorino;Salvatore Andreola;Elda Tagliabue;Francesco Pezzella

  • Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth

    N. Normanno;M. Campiglio;A. De Luca;G. Somenzi

  • Prognostic significance of HER-2/NEU expression in breast cancer and its relationship to other prognostic factors

    F Rilke;M I Colnaghi;N Cascinelli;S Andreola

  • FOXP3 Expression and Overall Survival in Breast Cancer

    Andrea Merlo;Patrizia Casalini;Maria Luisa Carcangiu;Chiara Malventano

  • Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

    Sylvie Mènard;Elda Tagliabue;Silvana Canevari;Giuseppe Fossati

  • HER2 as a prognostic factor in breast cancer.

    Sylvie Ménard;Stefania Fortis;Fabio Castiglioni;Roberto Agresti

  • N-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid

    Domenico Delia;Antonella Aiello;Luciano Lombardi;Pier Giuseppe Pelicci

Frequent Co-Authors

Maria I. Colnaghi
Maria I. Colnaghi University of Milan
Elda Tagliabue
Elda Tagliabue Fondazione IRCCS Istituto Nazionale dei Tumori
Andrea Balsari
Andrea Balsari University of Milan
Silvana Canevari
Silvana Canevari University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Vincent Castronovo
Vincent Castronovo University of Liège
Marco A. Pierotti
Marco A. Pierotti University of Bari Aldo Moro
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Jeanette A.M. Maier
Jeanette A.M. Maier University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative or complementary paths to a traditional medical degree in the USA? There are a variety of in-demand online degrees and career pathways that cater to diverse interests within healthcare.

rn to np bridge programs offer experienced registered nurses a fast-track route to become nurse practitioners through flexible online study. Similarly, if you’re seeking advancement without extensive on-campus requirements, online rn to bsn programs no clinicals provide a convenient, career-boosting option for RNs.

For those interested in the intersection of health, science, and nutrition, online nutrition degrees allow students to specialize in dietary science and wellness entirely through digital platforms.

Additionally, aspiring healthcare administrators can earn respected credentials with cahme accredited online mha programs, ensuring their qualifications meet the highest standards for leadership roles.

These flexible, accredited programs open numerous doors in clinical, administrative, and nutrition-related fields, providing a practical path into healthcare outside of medical school.

Best Scientists Citing Sylvie Ménard

Trending Scientists